ライフサイエンスコーパス: magnetic resonance angiography

1 ensional contrast material-enhanced coronary magnetic resonance angiography.

2 ast-enhanced thoracic computed tomography or magnetic resonance angiography.

3 vis with computed tomographic angiography or magnetic resonance angiography.

4 ethyl propionate, a known contrast agent for magnetic resonance angiography.

5 of in vivo vessels from contrast-enhanced 3D Magnetic Resonance Angiography.

6 onance imaging, bone densitometry, and brain magnetic resonance angiography.

7 % computed tomographic angiography, and 5.6% magnetic resonance angiography.

8 6 (47%) underwent baseline CT angiography or magnetic resonance angiography.

9 , 94% completed liver MRI, and 88% completed magnetic resonance angiography.

10 multifocal) based on computed tomographic or magnetic resonance angiography.

11 al flow and capillary formation evidenced by magnetic resonance angiography.

12 der who underwent thoracic contrast-enhanced magnetic resonance angiography.

13 ography of the aorta with either contrast or magnetic resonance angiography.

14 ant coronary artery narrowing was present by magnetic resonance angiography.

15 Aortic arch anatomy was assessed with magnetic resonance angiography.

16 confirmed using serial MAG3 renal scans and magnetic resonance angiography.

17 at doses that exceed those routinely used in magnetic resonance angiography.

18 arteries (84 percent) were interpretable on magnetic resonance angiography.

19 on x-ray angiography) were also detected by magnetic resonance angiography.

20 tential of ZES-SPIONs in preclinical MRI and magnetic resonance angiography.

21 es, including Duplex doppler velicometry and magnetic resonance angiography.

22 On 24-hour magnetic resonance angiography, 3 patients had no recana

23 enty-eight ADPKD patients were screened with magnetic resonance angiography, 40 ADPKD patients had co

24 trasonography (15% [56 175 of 376 149]), and magnetic resonance angiography (9% [34 026 of 376 149]).

25 large vessel occlusion confirmed with CT or magnetic resonance angiography admitted to endovascular

26 ronary angiogram, three-dimensional coronary magnetic resonance angiography allows for the accurate d

27 We investigated the accuracy of coronary magnetic resonance angiography among patients with suspe

28 and confirmed PSS presence in that subset by magnetic resonance angiography and (1)H-magnetic resonan

29 ties such as duplex Doppler ultrasonography, magnetic resonance angiography and computed tomographic

30 mparison, 360 patients without ADPKD who had magnetic resonance angiography and conventional angiogra

31 Magnetic resonance angiography and en face analyses demo

32 re the annual change in kidney blood flow by magnetic resonance angiography and the annual change in

33 Phase-contrast magnetic resonance angiography and ultrasound diameters

34 Technically adequate magnetic resonance angiography and venography had a sens

35 non-invasive imaging modalities such as MRA (Magnetic Resonance Angiography) and renal angiography at

36 c magnetic resonance (CMR), thoracoabdominal magnetic resonance angiography, and abdominal magnetic r

37 ate, computer tomographic angiography (CTA), magnetic resonance angiography, and angiography were per

38 re, lesion volume on DWI, arterial lesion by magnetic resonance angiography, and categorized elapsed

39 sive techniques, such as Doppler ultrasound, magnetic resonance angiography, and CT angiography, eith

40 nd mesenteric angiography with portal phase, magnetic resonance angiography, and intraoperative ultra

41 n angiography, computerized tomographic, and magnetic resonance angiography, and recently 18-FDG-PET.

42 relating to electron beam angiography (EBA), magnetic resonance angiography, and spiral computed tomo

43 assified according to computed tomography or magnetic resonance angiography as multifocal if there we

44 measured by difference in pixel summation in magnetic resonance angiography at 1 month and 6 months.

45 ic effects were quantified by phase contrast magnetic resonance angiography at baseline and after 120

46 Magnetic resonance angiography, averaged across centers,

47 Magnetic resonance angiography, being noninvasive, may r

48 anced thoracic aortic computed tomography or magnetic resonance angiography between 2003 and 2007.

49 To test whether magnetic resonance angiography can document the evolutio

50 maging (US, computed tomography angiography, magnetic resonance angiography), cardiac diagnostics (ec

51 y angiography and magnetic resonance imaging/magnetic resonance angiography), carotid imaging (US, co

52 t abnormal structural MRI (chi2; p = 0.7) or magnetic resonance angiography (chi2; p = 0.2) were not.

53 We reviewed data on cervical magnetic resonance angiography (cMRA) performed prospect

54 as judicious use of duplex ultrasonography, magnetic resonance angiography, computed tomography angi

55 Magnetic resonance angiography demonstrated sensitivity

56 clinical feasibility of deep learning-driven magnetic resonance angiography (DL-driven MRA) collatera

57 went both standard pulmonary angiography and magnetic resonance angiography during the pulmonary arte

58 cords to identify all patients who underwent magnetic resonance angiography from 1993 to 1999.

59 sonography, computed tomography angiography, magnetic resonance angiography, gastric tonometry, and m

60 Technically adequate magnetic resonance angiography had a sensitivity of 78%

61 Overall, coronary magnetic resonance angiography had an accuracy of 72 per

62 Alternative diagnostic studies such as magnetic resonance angiography have further narrowed the

63 Recent developments in renal magnetic resonance angiography have led to a significant

64 odalities, including computed tomography and magnetic resonance angiography, have allowed for more ac

65 patients with technically inadequate images, magnetic resonance angiography identified 57% (59 of 104

66 hypertension and unilateral RAS detected by magnetic resonance angiography, illustrates the challeng

67 the Circle of Willis vascular anatomy using magnetic resonance angiography images.

68 Moreover, magnetic resonance angiography in both AMS and non-AMS s

69 Another recent report proposed a role for magnetic resonance angiography in the diagnosis and foll

70 Three-dimensional time-of-flight magnetic resonance angiography, interpreted by 3 observe

71 Arterial tortuosity measured by magnetic resonance angiography is a reproducible marker

72 s are in reasonably well agreement with MRA (magnetic resonance angiography) measured ones.

73 fically, three-dimensional contrast-enhanced magnetic resonance angiography methods have been shown t

74 on, recent work has shown that variations of magnetic resonance angiography methods have several impo

75 Recent data show that magnetic resonance angiography methods may be used to pr

76 spectively corrected free-breathing coronary magnetic resonance angiography (MRA) allows for submilli

77 nts with acute ischemic stroke who underwent magnetic resonance angiography (MRA) and classified them

78 tandardized brain magnetic resonance imaging/magnetic resonance angiography (MRA) and transcranial Do

79 We sought to prospectively compare coronary magnetic resonance angiography (MRA) and x-ray coronary

80 Participants underwent magnetic resonance angiography (MRA) at 1.5T during LBNP

81 A Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA) brain showed a left

82 to determine whether gadolinium-enhanced 3D magnetic resonance angiography (MRA) can provide a nonin

83 ssel diameters and tortuosity changes) using magnetic resonance angiography (MRA) data.

84 Magnetic resonance angiography (MRA) demonstrated tight

85 women aged between 30 and 60 years, that had magnetic resonance angiography (MRA) during the period 2

86 Based on MRI/magnetic resonance angiography (MRA) findings, infarct s

87 study was to investigate the use of coronary magnetic resonance angiography (MRA) for assessing human

88 More recently, magnetic resonance angiography (MRA) has been compared w

89 3D T1-weighted and 3D magnetic resonance angiography (MRA) images were acquire

90 resonance imaging (MRI) and vasculopathy by magnetic resonance angiography (MRA) in children with he

91 olinium (Gd)-enhanced three-dimensional (3D) magnetic resonance angiography (MRA) in patients with co

92 ose of this study was to assess the value of magnetic resonance angiography (MRA) in the follow-up of

93 Magnetic resonance angiography (MRA) offers a noninvasiv

94 Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) studies, a neurolog

95 Label-free magnetic resonance angiography (MRA) was performed to lo

96 /CTA or magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) within 6 months of

97 AI on computed tomography angiography (CTA), magnetic resonance angiography (MRA), and cases of TVAI

98 ound, contrast-enhanced computed tomography, magnetic resonance angiography (MRA), and noncontrast MR

99 Non-invasive tests such as magnetic resonance angiography (MRA), computed tomograph

100 DSA), computed tomography angiography (CTA), magnetic resonance angiography (MRA), contrast-enhanced

101 ubmandibular Doppler sonography and cervical magnetic resonance angiography (MRA), could also be risk

102 r high-resolution 3D free-breathing coronary magnetic resonance angiography (MRA), coverage of the co

103 MRI, magnetic resonance angiography (MRA), Doppler ultrasound

104 igh-risk patients include fractional flow on magnetic resonance angiography (MRA), quantitative MRA,

105 All patients underwent magnetic resonance angiography (MRA), treadmill testing

106 extracoronary arterial beds was performed by magnetic resonance angiography (MRA).

107 dies have used standard Time-of-Flight (ToF) Magnetic Resonance Angiography (MRA).

108 maging (MRI) and ultrafast three-dimensional magnetic resonance angiography (MRA).

109 and more distal) from non-contrast enhanced magnetic resonance angiography (NCE-MRA) images, and exp

110 red for neuroimaging (computed tomography or magnetic resonance angiography of entire carotid tree an

111 m several times between 1998 and 2004 during magnetic resonance angiography of his abdominal vessels

112 contrast material-enhanced three-dimensional magnetic resonance angiography of the abdominal aorta an

113 Magnetic resonance imaging and magnetic resonance angiography of the brain were schedul

114 raphic examination of the liver and kidneys, magnetic resonance angiography of the brain, and echocar

115 titative flow was measured by phase-contrast magnetic resonance angiography of the cerebropetal vesse

116 this preliminary study, gadolinium-enhanced magnetic resonance angiography of the pulmonary arteries

117 l patients with abnormal renograms underwent magnetic-resonance angiography of the renal arteries as

118 asound may obviate confirmatory testing with magnetic resonance angiography or computed tomographic a

119 emangioma and radiological features based on magnetic resonance angiography or computed tomography an

120 of collaterals was diagnosed based on either magnetic resonance angiography or conventional angiograp

121 ed by planimetry from gadolinium-enhanced 3D magnetic resonance angiography (OR 1.71 for 10 mm2/m2 de

122 d on pre-MT computed tomography angiography, magnetic resonance angiography, or digital subtraction a

123 (0.4 or 0.2 mg/kg) or placebo, with cerebral magnetic resonance angiography performed at baseline and

124 Using phase-contrast magnetic resonance angiography (PMRCA), we measured hype

125 In 6 of those 8, cerebral angiography or magnetic resonance angiography results were normal, but

126 luate the benefits and cost-effectiveness of magnetic resonance angiography screening for IA in patie

127 nted by contrast angiography in 7 limbs; and magnetic resonance angiography showed qualitative eviden

128 Magnetic-resonance angiography showed severe renovascula

129 follow the motion of the coronary artery in magnetic resonance angiography, the authors evaluated ve

130 n vessel wall magnetic resonance imaging and magnetic resonance angiography to identify ICAD.

131 l intensity gradient (SIG) of Time-of-flight magnetic resonance angiography (TOF-MRA), referred to as

132 hibitively slow, non-invasive time-of-flight magnetic resonance angiography (TOF-MRA)-which is well s

133 terial recanalization by computed tomography/magnetic resonance angiography trended higher in warfari

134 y used examination for imaging surveillance, magnetic resonance angiography, ultrasonography, and dig

135 Magnetic resonance angiography verified prior results: t

136 The recanalization status on 24-hour magnetic resonance angiography was classified as none, p

137 Coronary magnetic resonance angiography was performed during free

138 Correlative magnetic resonance angiography was performed in 24 patie

139 Abdominal three-dimensional magnetic resonance angiography was performed in 35 patie

140 Three-dimensional free-breathing coronary magnetic resonance angiography was performed in eight he

141 Coronary magnetic resonance angiography was performed in eight he

142 Magnetic resonance angiography was performed to examine

143 e imaging (MRI), perfusion-weighted MRI, and magnetic resonance angiography were obtained at baseline

144 gely relied on X-ray computed tomography and magnetic resonance angiography with limited spatial reso

145 vasive method, gadolinium-enhanced pulmonary magnetic resonance angiography, with standard pulmonary

146 Among 35 patients who underwent magnetic resonance angiography within 30 days of random